Cell Cycle · 2015 · 11 citations · 29 references
MedicineOncologyPharmacologyApoptosisMolecular OncologyOncogenesApoptosis RegulationCancer Stem CellsCell Cycle PharmacologyChemotherapy In Hematologic MalignanciesChemotherapy ResistanceTyrosine Kinase InhibitorsBcr-abl InhibitorsChronic Myeloid Leukemia TherapyDna Damage InductionKinase InhibitorsLow-oxygen StressOxidative Dna DamagePrimary CellsProgenitor Cells
We previously showed that incubation of chronic myeloid leukemia (CML) cells in very low oxygen selects a cell subset where the oncogenetic BCR/Abl protein is suppressed and which is thereby refractory to tyrosine kinase inhibitors used for CML therapy. In this study, salarin C, an anticancer macrolide extracted from the Fascaplysinopsis sponge, was tested as for its activity on CML cells, especially after their incubation in atmosphere at 0.1% oxygen. Salarin C induced mitotic cycle arrest, apoptosis and DNA damage. Salarin C also concentration-dependently inhibited the maintenance of stem cell potential in cultures in low oxygen of either CML cell lines or primary cells. Surprisingly, the drug also concentration-dependently enforced the maintenance of BCR/Abl signaling in low oxygen, an effect which was paralleled by the rescue of sensitivity of stem cell potential to IM. These results suggest a potential use of salarin C for the suppression of CML cells refractory to tyrosine kinase inhibitors.
29
François‐Xavier Mahon, Delphine Réa, Joëlle Guilhot et al. · The Lancet Oncology · 2010 · 1.5K citations
Direct measurement of local oxygen concentration in the bone marrow of live animals
Joel A. Spencer, Francesca Ferraro, Emmanuel Roussakis et al. · Nature · 2014 · 1.1K citations · Full text